Entheon Biomedical(DE:1XU)
€0.030.00 (0.00%)
DE:1XU
Entheon Biomedical financials statements
€0.03
At close:0.00 (0.00%)
Entheon Biomedical (1XU) Income Statement
0 Followers
Entheon Biomedical Income Statement
Last quarter (Q4 2025), Entheon Biomedical's total revenue was C$0.00. In Q4, Entheon Biomedical's net income was C$-65.01K. See Entheon Biomedical’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 250.32K | C$ 189.68K | C$ 21.67K | |
| C$ 0.00 | C$ 0.00 | C$ 250.32K | C$ 189.68K | C$ 9.13K | |
| C$ 334.22K | C$ 332.66K | C$ 564.32K | C$ 3.79M | C$ 8.21M | |
| Depreciation and Amortization | C$ 0.00 | C$ 332.66K | C$ 313.99K | C$ 2.10K | C$ 3.84K |
| C$ -334.22K | C$ -318.00K | C$ 13.99K | C$ -3.60M | C$ -8.21M | |
| C$ -334.22K | C$ -333.00K | C$ -313.00K | C$ -3.60M | C$ -8.21M | |
| C$ 10.21K | C$ 14.74K | C$ 12.81K | C$ 1.54M | C$ 215.87K | |
| C$ -324.01K | C$ -318.00K | C$ -300.00K | C$ -2.06M | C$ -8.00M | |
| C$ -324.01K | C$ -318.00K | C$ -300.00K | C$ -8.52M | C$ -8.89M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.02 | C$ -0.04 | C$ -0.05 | C$ -0.14 | C$ -0.16 |
| Diluted EPS | C$ -0.02 | C$ -0.04 | C$ -0.05 | C$ -0.14 | C$ -0.16 |
| Weighted Average Shares Outstanding | 13.41M | 7.74M | 5.91M | 59.09M | 56.83M |
| Weighted Average Shares Outstanding (Diluted) | 13.41M | 7.74M | 5.91M | 59.09M | 56.87M |
Currency in CAD
